Post-transcriptional modifications in eukaryotic RNAS A. addition of CCA at the 5'end of the RNA for binding with amino acids B. removal of introns and possibility of alternative splicing in joining different exons C. addition of guanyly residue from GTP to nascent MRNA at the 5' end D. Ten (10) Adenine nucleotides are added to the 3'end of the nascent MRNA E. some bases are modified in tRNA and rRNA (A) А, В, С, Е only в) А, В, С, D only C) A, B, C, D, E D B, C, E only

Post-transcriptional modifications in eukaryotic RNAS A. addition of CCA at the 5'end of the RNA for binding with amino acids B. removal of introns and possibility of alternative splicing in joining different exons C. addition of guanyly residue from GTP to nascent MRNA at the 5' end D. Ten (10) Adenine nucleotides are added to the 3'end of the nascent MRNA E. some bases are modified in tRNA and rRNA (A) А, В, С, Е only в) А, В, С, D only C) A, B, C, D, E D B, C, E only

Name: Post-transcriptional modifications in eukaryotic RNASA. addition of C
Uploaded: 2024-03-20T06:42:41.000Z
Channel: Bartleby
Description: Post-transcriptional modifications in eukaryotic RNASA. addition of CCA at the 5'end of the RNA for binding with amino acidsB. removal of introns and possibility of alternative splicing in joining different exonsC. addition of guanyly residue from G

Biochemistry

6th Edition

ISBN:9781305577206

Author:Reginald H. Garrett, Charles M. Grisham

Publisher:Reginald H. Garrett, Charles M. Grisham

Chapter29: Transcription And The Regulation Of Gene Expression

Section: Chapter Questions

Problem 18P

See similar textbooks

Similar questions

Bacteria or Eukaryotes? Formation of a termination loop within the transcript Alternative splicing of transcripts Translation beginning before transcription is complete Cleavage following the AAUAAA signal Direct binding of RNA polymerase to promoter
The three stages of transcription (initiation, elongation, and termination) – with a focus on how RNA Polymerase II (Pol II) relates to these stages. The final product of transcription
Describe what happens to the chemical bonding interactions when transcriptional termination occurs. Be specific about the type of chemical bonding.
in human genome if any example of mRNA that are translated from two possible region and are both functions and any disease associated with that .
The transcriptional complement of the DNA strand with the code 3’ TAA-CAT-GCT 5’ is
Alternative Splicing Possibilities Suppose exon 17 were deleted from the fast skeletal muscle troponin T gene (Figure 29.46). How many different mRNAs could now be generated by alternative splicing? Suppose that exon 7 in a wild-type troponin T gene were duplicated. How many different mRNAs might be generated from a transcript of this new gene by alternative splicing?
A scientist mutates elF-2 to eliminate its GTP hydrolysis capability. How would this mutated form of elF-2 alter translation? Initiation factors would not be able to bind to mRNA The large ribosomal subunit would not be able to interact with itiRNA transcripts tRNAi-Met would not scan mRNA transcripts for the start codon elF-2 would not be able to interact with the small ribosomal subunit.
Comparison of Prokaryotic and Eukaryotic Transcription Make a list of the ways that transcription in eukaryotes differs from transcription in prokaryotes.
The Lariat Intermediate in RNA Splicing Draw the structures that comprise the lariat branch point formed during mRNA splicing: the invariant A. its 5â€™-R neighbor, its 3â€™-Y neighbor, and its 2â€™-G neighbor.
Amino acid sequences from a cell cycle control protein from a patient with cancer and a healthy person are aligned. The sequence from the cancer patient indicates one amino acid has changed from phenylalanine (Phe) to leucine (Leu). A mutation in the cancer patient's DNA must have taken place. Identify the result of this DNA change in the mRNA codon that led to this change in the protein sequence. Use the codon table to help you. UUU altered to UUA CAA altered to UUU UUU altered to UAU
Hemophilia in the Russian royal family was caused by defective protein involved in blood clotting (factor IX). This defective protein was caused by a mutation that altered the splicing of the exons. This genetic change in the splicing pattern created a new stop codon in the mRNA for factor IX. Is it likely that the mutation has altered at least one base at the exon-intron boundary in the wild-type pre-mRNA? Why or why not?
Transcriptional regulation You are interested in studying the transcriptional regulation of Glp1 promoter. This gene contains a binding site for two proteins A and B. Proteins A and B cannot bind to the DNA at the same time due to steric interference caused by a slight overlap in their binding sites. The binding sites of protein A and protein B can be seen in the figure below. Protein A binds to Site C and Protein B binds to site D. To assess whether either A or B have an influence on Glp1 expression, you create mutations in the DNA that selectively remove the non-overlapping sequences of binding site C or binding site D. You then examine Glp1 mRNA production within adult liver cells. You receive the following data. Experiment number Binding site C Binding site D Glp1 mRNA levels 1 + + high 2 + - high 3 - + none 4 - - none += binding site present, -= binding site absent What does this data tell us about which protein is…